S&P DJI Announces March 2022 Quarterly Rebalance
Filed with ASX · · 10 pages · English
Australian Clinical Labs Ltd on 6ix
Earlier from Australian Clinical Labs
- Establishment of Dividend Reinvestment Plan
- Media Release - 1H22 Financial Results
- 1H22 Investor Presentation
- Appendix 4D
- Letter from Crescent Capital Partners
Later from Australian Clinical Labs
- Response to Market Enquiries
- FY22 Investor Presentation
- Appendix 4E - Preliminary Financial Report
- Letter received from Crescent Capital
- Second letter from Crescent Capital
Follow Australian Clinical Labs into a list and get an email when it puts out news.
Follow Australian Clinical Labs